The Sefia platform is a patent pending technology developed for cell and gene therapy manufacturing. It combines with dedicated software and single-use kits to process both small and large volumes of cellular material. Sefia offers adaptive solutions to automate any cell processing workflow, such as:
Preparation | Isolation | Washing | Concentration | Final formulation
Commercial release pending and for investigational use only.
Process up to 10 L/h
Up to eight fluid pathways
A closed and sensor controlled system
Full process traceability
Sefia works in exclusive combination with the FlexCell protocol and CT-800.1 single-use kit. Select one for more information.